Related Experiment Video

Updated: Oct 8, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

776

[Application progress of polymyxin in bloodstream infection of drug-resistant Acinetobacter baumannii]

Shuguang Zhang1, Liutao Sun, Limin Sun

  • 1Department of Critical Care Medicine/General Intensive Care Unit (2), the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450018, Henan, China. Corresponding author: Zhang Shuguang,

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
|January 4, 2022
PubMed

Insights

Polymyxin is a crucial antibiotic for treating severe bloodstream infections caused by drug-resistant Gram-negative bacteria, particularly carbapenem-resistant Acinetobacter baumannii (CRAB). This review examines its clinical use for CRAB infections, offering guidance for effective antimicrobial therapy.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Rising rates of Gram-negative bacilli bloodstream infections, especially drug-resistant strains.
  • Carbapenem-resistant Acinetobacter baumannii (CRAB) presents a significant clinical challenge with high mortality.
  • Polymyxins, available since the 1950s, exhibit activity against multidrug-resistant Gram-negative bacteria.

Purpose of the Study:

  • To review the clinical application of polymyxin in treating bloodstream infections caused by drug-resistant Acinetobacter baumannii.
  • To provide a reference for clinical medication strategies against CRAB infections.

Main Methods:

  • Literature review of clinical studies and treatment guidelines.
  • Analysis of polymyxin's role in managing Gram-negative bacilli infections.

Main Results:

  • Polymyxin demonstrates antibacterial activity against multidrug-resistant and extensively drug-resistant Gram-negative bacilli.
  • It serves as an effective agent for permeating the cell envelope of Gram-negative bacilli.
  • The World Health Organization designates polymyxin as a critical antimicrobial for treating infections like CRAB.

Conclusions:

  • Polymyxin is a vital therapeutic option for severe infections caused by drug-resistant Gram-negative bacteria, including CRAB.
  • Its use is reserved for microbiologically confirmed infections where other options are limited.
  • This review aims to guide clinicians in optimizing polymyxin therapy for CRAB bloodstream infections.

More Related Videos

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis07:16

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

1.3K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.6K

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
66
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
18
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
299
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
293